Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-17-008354

Director bought 45,200 shares at an average $1.20 ($54,190)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-22 Purchase : show line 1 in the form +5,200 $1.21 $6,273 16,010,000 D
2017-11-22 Purchase : show line 2 in the form +0 16,010,000 I
2017-11-22 Purchase : show line 3 in the form +0 16,010,000 I
2017-11-22 Purchase : show line 4 in the form +30,000 $1.20 $35,937 16,040,000 D
2017-11-22 Purchase : show line 5 in the form +0 16,040,000 I
2017-11-22 Purchase : show line 6 in the form +0 16,040,000 I
2017-11-24 Purchase : show line 7 in the form +5,000 $1.20 $5,990 16,045,000 D
2017-11-24 Purchase : show line 8 in the form +0 16,045,000 I
Open-market purchases · 45,200 sh · avg $1.20 · $54,190
Loading xslF345X03/p7745463.xml…